Prevalence of hepatitis B surface antigen (HBsAg) and its risk factors among individuals visiting Goba General Hospital, South East Ethiopia, 2012

BMC Research Notes

Tomas Benti Tefera²  Asfaw Negero Erena¹ 

[1] Department of Medicine, Madawalabu University, College of Medicine and Health Sciences, Bale-Goba, South East Ethiopia;Department of Nursing, Madawalabu University, College of Medicine and Health Sciences, Bale-Goba, South East Ethiopia

关键词: Goba Ethiopia;    Madawalabu University;    Co infection;    Human Immuno Deficiency Virus (HIV);    Hepatitis B Virus (HBV);   

Others  :  1118294
DOI  :  10.1186/1756-0500-7-833

 received in 2014-08-22, accepted in 2014-11-18,  发布年份 2014

【 摘 要 】

Background

Hepatitis B virus infection is a significant health problem. Approximately two billion people worldwide have chronic Hepatitis B virus infection and over one million die annually. Hepatitis B virus infection and Human Immunodeficiency Virus co-infection is an emerging concern in the clinical management of patients because of shared routes of transmission.

Methods

Hospital based cross-sectional study was performed from January to June, 2012 at Goba General Hospital. Socio-demographic and possible risk factors data from study subjects were collected using pre-test and structured questionnaire. Venous blood was collected and the serums were tested for Hepatitis B surface antigen and Human Immune Deficiency Virus using commercially available rapid test kits. Data were entered and analyzed using the SPSS software package (version15). Binary and multivariable logistic regressions were used to identify factors associated factors. A p-value of <0.05 was considered statistical significant.

Result

The prevalence of Hepatitis B surface Antigen in this study group was 26 (7.4%). Prevalence of Hepatitis B Human Immune Deficiency Virus Co-infection was about 9 (42.3%) and about 17 (5.1%) of Human Immuno Deficiency Virus negative subjects were positive for Hepatitis B surface Antigen. Risk factors like, hospital admission, multiple sexual partners, HIV status, and unsafe drug injection were found to have significant association with Hepatitis B surface Antigen on binary logistic regression. However, multiple sexual partners and being positive for Human Immuno Deficiency Virus infection were the only significantly associated with Hepatitis B Virus on multivariable logistic regression.

Conclusion

Even though Hepatitis B surface Antigen prevalence is higher among subjects who are Human Immuno Deficiency Virus positive, screening program has to be started in the hospital for all clients regardless of their disease status to prevent the potential spread of the infection.

【 授权许可】

   
2014 Erena and Tefera; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Feitelson MA, Sun B, Satiroglu Tufan NL, Liu J, Pan J, Lian Z: Genetic mechanisms of hepatocarcinogenesis. Oncogene 2002, 21:2593-2604.
• [2]Mahoney FJ, Kane M: Hepatitis B Vaccine. In Vaccines. 3rd edition. Edited by Plotkin SA, Orenstein WA. Philadelphia: W.B. Saunders Company; 1999:158-182.
• [3]Martin C, Lilian H, Irma E, Ibarra R, Irma H, Fernandez G, Jorge E: Prevalence of HBV infection and risk factors in a rural community of Mexico. Am J Trop Med Hyg 2001, 65(6):759-763.
• [4]Kane M: Global programme for control of hepatitis B infection. Vaccine 1995, 13:47-49.
• [5]Kane A, Lloyd J, Zaffran M, Simonsen L, Kane M: Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bull WHO 1999, 77(10):801-807.
• [6]Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV: Global epidemiology of hepatitis B virus. J Clin Gastroenterol 2004, 38:158-168.
• [7]Bwogi J, Braka F, Makumbi I, Mishra V, Bakamutumaho B, Nanyunja M, Opio A, Downing R, Biryahwaho B, Lewis RF: Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey. Afr Health Sci 2009, 9:98-108.
• [8]Abebe A, Messele T, Dejene A, Enquselassie F, Messele T, Cutts F: Sero epidemiological study of hepatitis B virus in Addis Ababa, Ethiopia: transmission patterns and vaccine control. Epidemiol Infect 2003, 131:757-770.
• [9]Negero A, Sisay Z, Medhin G: Prevalence of hepatitis B surface antigen (HBsAg) among visitors of shashemene general hospital voluntary counselling and testing center. BMC Res Notes 2011, 4:35. BioMed Central Full Text
• [10]Kupek E: Residual transmission risk for hepatitis B and C in South Brazil, 1991–99. J Viral Hepat 2001, 8:78-82.
• [11]Smelzer SC, Bare B: Brunner and Suddarth’s Textbook of Medical Surgical Nursing. Philadelphia: Lippincott Williams and Wiking; 2003.
• [12]Burnett RJ, Francois G, Kew MC, Leroux-Loels G, Meheus A, Moosen AA, Mphahlele M: Hepatitis B virus and human immune deficiency virus co-infection in sub Saharan Africa, a call for further investigation. Liver Int 2005, 25(2):201-224.
• [13]Shimelis T, Torben W, Medhin G, Tebeje M, Adualem A, Demessie F, Mulu A, Tegbaru B, Gebre-Selassie S: Hepatitis B virus infection among people attending the voluntary counseling and testing center and anti retroviral therapy clinic of St Paul’s general specilaized hospital Addis Ababa, Ethiopia. Sex Trans Infect 2008, 84(1):37-41.
• [14]Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM: High risk of occult hepatitis b virus infection in HIV-positive patients from South Africa. J Clin Virol 2006, 35:14-20.
• [15]Nunez M, Puoti M, Camion N, Soriano V: Treatment of chronic hepatitis b in the human immunodeficiency virus infected patients: present and future. Clin Infect Dis 2003, 37:1678-1685.